Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunophenotypic Characterization of Crohn's Disease (CD) Responders to Vedolizumab

NCT04909359 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT04909359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04909359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunophenotypic Characterization of Crohn's Disease (CD) Responders to Vedolizumab
Lead sponsor
University of Miami
Phase
Observational
Overall status
Completed
Start date
August 25, 2015
Completion date
May 18, 2020
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, ulcerative colitis